Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    ART-123
Show Display Options
Rank Status Study
1 Recruiting Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ART-123;   Drug: Placebo
2 Unknown  Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
Condition: Disseminated Intravascular Coagulation
Intervention: Drug: ART-123
3 Recruiting Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer
Condition: Postoperative Stage II/III Colon Cancer
Interventions: Drug: ART-123 (High Frequency);   Drug: ART-123 (Low Frequency);   Drug: Placebo
4 Recruiting Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Conditions: Severe Sepsis;   Coagulopathy
Interventions: Drug: ART-123;   Drug: Placebo
5 Completed Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
Conditions: Sepsis;   Disseminated Intravascular Coagulation
Interventions: Drug: ART-123;   Drug: placebo
6 Withdrawn Study to Look at the Effects of ART-123 on Patients With Sepsis and Disseminated Intravascular Coagulation (DIC)
Conditions: Disseminated Intravascular Coagulation;   Sepsis
Interventions: Drug: ART-123;   Drug: placebo

Indicates status has not been verified in more than two years